Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects

Clinical trial NCT01150812 · TERMINATED

Trial details

NCT number: NCT01150812
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Thrombin Inhibition

Start date: 2010-06-01
Primary completion: 2010-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.